Brokerages expect that Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) will report sales of $97.12 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Amphastar Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $91.50 million and the highest estimate coming in at $101.70 million. Amphastar Pharmaceuticals posted sales of $84.69 […]
